欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子抑制剂 > Endocrinology/Hormones > Mirtazapine

浏览历史

S81014

Mirtazapine

源叶(MedMol) 99%
  • 英文名:
  • Mirtazapine
  • 别名:
  • 米氮平;1,2,3,4,10,14b-六氢-2-甲基吡嗪基-[2,1-a]吡啶并[2,3-C]氮杂卓;1,2,3,4,10,14B-Hexahydro-2-Methylpyrazino[2,1-A]Pyrido[2,3-C][2]Benzazepine;(rs)-1,2,3,4,10,14b-Hexahydro-2-Methylpyrazino-[2,1-a]Pyrido[2,3-c][2]Ben
  • CAS号:
  • 85650-52-8
  • 分子式:
  • C17H19N3
  • 分子量:
  • 265.35
  • MDL:
  • MFCD00865427
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S81014-100mg 99% ¥370.00元 1 - - - EA 加入购物车
源叶(MedMol) S81014-500mg 99% ¥1300.00元 预计交期:2-3天 - - - EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 产品描述: Mirtazapine (Org3770) is a potent and orally active noradrenergic and specific serotonergic antidepressant (NaSSA) agent. Mirtazapine is also a 5-HT2, 5-HT3, histamine H1 receptor and α2-adrenoceptor antagonist with pKi values of 8.05, 8.1, 9.3 and 6.95, respectively
  • 靶点: 5-HT3 Receptor:8.1 (pKi);5-HT2 Receptor:8.05 (pKi);H1 Receptor:9.3 (pKi);α2-adrenergic receptor:6.95 (pKi);DopamineReceptor; 5-HTReceptor; OpioidReceptor; AdrenergicReceptor; HistamineReceptor
  • 体外研究:
    Mirtazapine can antagonize the adrenergic α2-autoreceptors and α2-heteroreceptors as well as block 5-HT2 and 5-HT3 receptors. Mirtazapine enhances the release of norepinephrine and 5-HT1A-mediated serotonergic transmission. The cytochrome (CYP) P450 isoenzymes CYP1A2, CYP2D6, and CYP3A4 are mainly responsible for Mirtazapine's metabolism. Mirtazapine (10 μM) significantly reduces activation-induced release of cytokine/chemokine mediators from human CD14+ monocytes in vitro
  • 体内研究:
    Mirtazapine (1-20 mg/kg; intraperitoneal injection; once; C57BL/6 mice) treatment strikingly and dose-dependently inhibits Con A-induced liver injury. Mirtazapine treatment inhibits hepatic macrophage/monocyte activation, decreases hepatic macrophage/monocyte-derived pro-inflammatory cytokine (e.g., TNFα) and chemokine (e.g., CXCL1 and CXCL2) production, suppression of Con A-induced increases in the hepatic expression of the neutrophil relevant endothelial cell adhesion molecule ICAM-1, with the resultant significant reduction in neutrophil recruitment into the liver. Animal Model: Male C57BL/6 mice (8-10 week old) treated with concanavalin A (Con A) Dosage: 1 mg/kg, 10 mg/kg, and 20 mg/kg Administration: Intraperitoneal injection; once Result: Strikingly and dose-dependently inhibited Con A-induced liver injury.
  • 参考文献:
    1. S A Anttila, et al. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev. Fall 2001;7(3):249-64. 2. T H de Boer, et al. Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers. Neuropharmacology. 1988 Apr;27(4):399-408. 3. Wagdi Almishri, et al. The Antidepressant Mirtazapine Inhibits Hepatic Innate Immune Networks to Attenuate Immune-Mediated Liver Injury in Mice. Front Immunol. 2019 Apr 12;10:803.
  • 溶解性: Soluble  in  DMSO、H2O
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 3.769 ml 18.843 ml 37.686 ml
    5 mM 0.754 ml 3.769 ml 7.537 ml
    10 mM 0.377 ml 1.884 ml 3.769 ml
    50 mM 0.075 ml 0.377 ml 0.754 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。